Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3
Clinical trial NCT05738980 · RECRUITING
Trial details
- NCT number
- NCT05738980
- Sponsor
- Beijing Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2025-12-31
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.